What Catatonia Actually Does to the Brain and Body

Catatonia is a highly treatable psychomotor syndrome that disrupts the brain's motor-intention pathways across mood disorders, autoimmune conditions, and other psychiatric causes, and the fear, disorientation, and grief that patients and caregivers carry after an episode often benefit from structured, evidence-based therapeutic support.

Catatonia is one of the most frightening things a family can witness, but also one of the most treatable psychiatric emergencies in modern medicine. That gap between how it looks and how it responds to treatment is exactly what this article is here to close.

What is catatonia?

Catatonia looks frightening. A person may stop moving entirely, stare blankly for hours, or hold an unusual posture without any apparent awareness of the world around them. It is easy to understand why this can feel like watching someone disappear. But here is what matters most: catatonia is one of the most treatable acute psychiatric emergencies in modern medicine. Benzodiazepines, the first-line treatment, produce a response in roughly 70–80% of cases, according to clinical research on benzodiazepines and electroconvulsive therapy as first-line catatonia treatments. When benzodiazepines are not enough, electroconvulsive therapy (ECT) is effective in approximately 85–90% of cases. Even in its most dangerous form, malignant catatonia, modern treatment has reduced mortality from over 50% to under 10%.

Catatonia is a psychomotor syndrome, meaning it disrupts the connection between thinking and movement. It is not a standalone diagnosis. In the DSM-5-TR, the manual clinicians use to diagnose mental health conditions, catatonia appears as a specifier: a descriptor that can be attached to other diagnoses rather than a condition that stands alone. DSM-5-TR diagnostic criteria estimate that catatonia affects 5–20% of psychiatric inpatients, which makes it far more common than most people realize.

What catatonia actually looks like

The symptoms of catatonia fall into several clusters, and not all of them fit the image of someone frozen in place. The condition can present as:

• Stupor and mutism: A person becomes largely unresponsive and stops speaking
• Rigidity and posturing: The body holds stiff or unusual positions for extended periods
• Waxy flexibility: A person’s limbs can be repositioned by someone else and will stay in place, like soft wax
• Echopraxia and echolalia: Automatically mimicking another person’s movements or words
• Extreme agitation: Purposeless, frantic motor activity that can look like the opposite of being frozen

That last point is worth emphasizing. Catatonia does not always mean stillness. The agitated subtype can involve intense, uncontrolled movement, which is why the condition is sometimes missed or misread.

Catatonia is not just a schizophrenia symptom

For decades, catatonia was assumed to be a feature of schizophrenia. That assumption is outdated. Research shows that catatonia actually occurs more frequently alongside mood disorders such as bipolar disorder and major depressive disorder than it does with schizophrenia. It can also arise from autoimmune conditions, metabolic disturbances, and toxic or drug-related causes. Understanding this broader picture is the first step toward recognizing catatonia for what it truly is: a well-characterized neuropsychiatric syndrome with a clear path to treatment.

What causes catatonia?

Catatonia does not have a single cause. It can emerge from a wide range of psychiatric, neurological, and medical conditions, which is part of what makes it so frequently misunderstood. Knowing the full picture helps caregivers and patients push for the right diagnosis faster.

Psychiatric conditions linked to catatonia

Contrary to popular belief, schizophrenia is far from the most common psychiatric trigger. Bipolar disorder, particularly during manic or mixed episodes, is one of the leading psychiatric causes. Major depressive disorder can also produce catatonic states, especially in severe episodes where a person becomes profoundly withdrawn or unresponsive.

Schizophrenia spectrum disorders do carry a risk, but they account for a smaller share of cases than many people assume. Autism spectrum disorder (ASD) is another important cause. Research from the National Autistic Society shows that catatonia affects an estimated 12 to 17 percent of autistic adolescents and adults, often appearing as a gradual increase in movement difficulties and freezing episodes.

Medical and autoimmune causes

Some of the most serious catatonic episodes have purely medical origins. Autoimmune encephalitis, particularly anti-NMDA receptor encephalitis (a condition where the immune system mistakenly attacks brain receptors), is a well-documented trigger. Infections affecting the brain, metabolic disturbances like hepatic encephalopathy (liver-related brain dysfunction) and electrolyte imbalances, and endocrine disorders such as thyroid dysfunction can all produce catatonic symptoms.

Toxic exposures matter too. Abrupt withdrawal from benzodiazepines or dopaminergic medications, which regulate dopamine signaling in the brain, is a recognized cause. Certain drug interactions can also tip a vulnerable person into a catatonic state. This is why a thorough medical workup is always part of responsible catatonia care.

Why assuming catatonia equals schizophrenia is wrong and harmful

The assumption that catatonia equals schizophrenia is not only inaccurate but can delay life-saving treatment. The DSM-5 formally decoupled catatonia from schizophrenia, recognizing it as a syndrome that spans a broad range of psychiatric, toxic, metabolic, and immunological conditions. Labeling someone’s catatonia as a schizophrenia symptom when the real cause is an autoimmune condition or a medication interaction means the underlying problem goes untreated.

In up to 20 percent of cases, no single clear cause is identified right away. That uncertainty does not change the treatment approach. Clinicians treat the catatonia directly while continuing to investigate the root cause, because both problems deserve attention at the same time.

What is happening inside the brain during catatonia?

To understand catatonia, it helps to start with a single brain chemical: GABA. GABA is the brain’s primary inhibitory neurotransmitter, meaning its job is to calm neural activity and keep signaling smooth and controlled. When GABA-A receptors stop working properly, a condition researchers call GABA-A hypofunction, the brain loses its ability to regulate motor planning and execution. According to research on GABA deficiency and glutamate hyperactivity as neurochemical mechanisms in catatonia, this failure in inhibitory signaling is a core driver of the catatonic state, which is why treatments that restore GABA activity work so reliably.

Consider a circuit breaker: your home’s electrical panel prevents a power surge from destroying your appliances by tripping a breaker and cutting the flow. Catatonia works similarly. When the brain’s motor-intention pathways become overwhelmed or dysregulated, the system trips, shutting down voluntary movement or flooding the body with purposeless, repetitive activity as a protective response. This is not a psychological choice or a sign of weakness. It is a circuit-level failure that the brain, in a disorganized way, is trying to manage.

The specific loop involved connects three key areas: the prefrontal cortex, the basal ganglia, and the thalamus. Together, these regions form a circuit that translates intention into action. Neuroimaging research identifying supplementary motor area hyperperfusion as a marker of catatonia shows measurable dysregulation in exactly these motor-intention pathways. When this cortical-subcortical loop breaks down, the translation from intention to action fails, and the person becomes frozen, agitated, or both.

This also explains why benzodiazepines are the first-line treatment. They effectively reset the tripped breaker by restoring the inhibitory signaling the brain lost. The lorazepam challenge, where a clinician gives a small dose and watches for rapid improvement, works as both a diagnostic test and a treatment for exactly this reason.

Most importantly: this is a functional disruption, not structural brain damage. The brain’s architecture is intact. When the neurochemistry is corrected, function returns. Catatonia looks permanent from the outside, but at the biological level, it is a state the brain can exit.

Signs and symptoms of catatonia

Most people picture catatonia as a person frozen in place, completely unresponsive to the world around them. That image is real, but it only captures part of the picture. Catatonia spans a wide range of behaviors, and missing the less familiar signs is exactly how the condition goes unrecognized and untreated.

When catatonia looks like stillness

The quieter, hypokinetic form of catatonia is what clinicians sometimes call the retarded presentation. A person experiencing this may fall into a stupor, meaning they appear awake but do not respond to voices, touch, or pain. They may stop speaking entirely (mutism), hold an unusual body position for an unnervingly long time without seeming to notice discomfort (posturing), or allow their limbs to be moved into a new position and then stay there, like soft wax being shaped (waxy flexibility). Some people stop eating, drinking, or making eye contact. Withdrawal from basic self-care is common. To a caregiver watching from the doorway, it can look like severe depression, a medical collapse, or even willful silence.

When catatonia looks like agitation

Catatonia can also run in the opposite direction. The excited, hyperkinetic presentation involves purposeless, driven agitation that does not seem connected to any clear goal or emotion. A person may repeat the same meaningless phrase over and over (called verbigeration), make repetitive movements or gestures (stereotypies), grimace continuously, or become combative when approached. This version of catatonia is frequently mistaken for a manic episode, acute psychosis, or drug intoxication. Some people alternate between stupor and agitation within a single day, which makes the pattern even harder to identify without a structured assessment.

What the Bush-Francis scale measures in plain language

Clinicians use the Bush-Francis Catatonia Rating Scale to screen for and rate catatonia severity. It covers 23 items that span both the hypokinetic and hyperkinetic presentations. Some of those items translate directly into what a caregiver might observe at the bedside:

• Posturing: holding an unusual position, like an outstretched arm or tilted head, for a minute or longer without apparent discomfort
• Negativism: resisting any attempt to be moved or examined, even when the person does not explain why
• Ambitendency: starting a movement, stopping, starting again, and never completing it, as if stuck in a loop
• Echopraxia: automatically copying the movements of whoever is nearby

The bedside exam that uses this scale takes only a few minutes. Catatonia is often missed not because it is subtle, but because clinicians do not routinely test for it. Identifying it early can change the entire course of treatment.

How is catatonia diagnosed?

Unlike many medical conditions, catatonia does not show up on a brain scan or blood test. Diagnosis happens at the bedside, through direct clinical observation. According to the DSM-5, a clinician needs to identify at least 3 of 12 specified features, such as stupor, mutism, posturing, waxy flexibility, or stereotypy, before a catatonia diagnosis can be confirmed. This makes the clinician’s trained eye the most important diagnostic tool in the room.

In emergency and inpatient settings, this process moves quickly. A psychiatrist or neurologist examines the patient, documents which features are present, and then moves almost immediately to the next step: a test that is also the first treatment.

The lorazepam challenge: a 30-minute test that is also the first treatment

The lorazepam challenge is one of the more elegant procedures in psychiatry. The clinician administers 1 to 2 mg of lorazepam (a benzodiazepine sedative) intravenously, then re-examines the patient within 5 to 30 minutes. If catatonic signs improve markedly, that response confirms the diagnosis. The test and the treatment happen in the same 30-minute window.

What does a positive response actually look like? A patient who was mute may begin to speak. Fixed, vacant eyes may make contact again. Rigid limbs may soften. Unusual postures may resolve. In some cases, the change is dramatic: a person who appeared completely unreachable begins responding to questions within minutes. As outlined in clinical diagnosis and treatment of catatonia, this kind of rapid, multidisciplinary assessment is central to how modern neuropsychiatry approaches the condition.

The clinician documents exactly which symptoms improved and by how much, building a baseline that guides all subsequent treatment decisions.

Ruling out conditions that mimic catatonia

Neuroleptic malignant syndrome (NMS) is caused by antipsychotic medications and shares features like rigidity and altered consciousness, but NMS also produces distinct autonomic instability: fever, sweating, and dangerous fluctuations in blood pressure and heart rate. Some antipsychotics that might otherwise be considered can worsen catatonia, so ruling out NMS first is critical.

Serotonin syndrome and status epilepticus (prolonged seizure activity) can also produce altered states that resemble catatonia. An EEG helps rule out seizure activity, while a detailed medication history points toward or away from serotonin syndrome.

Labs and imaging are still ordered, not to diagnose catatonia, but to find the underlying cause. Autoimmune panels, metabolic workups, MRI, and EEG help identify whether something like anti-NMDA receptor encephalitis, a thyroid crisis, or another treatable condition is driving the episode. Treating the root cause is what makes long-term recovery possible.

Why antipsychotics can make catatonia worse and what to say to ER staff

One of the most clinically urgent facts about catatonia is also one of the least widely known: antipsychotic medications, which are commonly used in psychiatric emergencies, can actually worsen catatonia and increase the risk of life-threatening complications. Understanding why this happens, and knowing how to communicate it calmly in an emergency setting, could make a meaningful difference for someone you love.

How antipsychotics interfere with catatonia treatment

Antipsychotic medications work by blocking dopamine D2 receptors in the brain. In most psychiatric emergencies, this is precisely the goal. Catatonia, though, involves a disruption in the motor and behavioral circuits that depend on dopamine signaling to function. When D2 receptors are blocked during active catatonia, that disruption can deepen, potentially prolonging the episode or triggering a dangerous escalation called neuroleptic malignant syndrome (NMS), a severe condition involving high fever, muscle rigidity, and organ stress.

A systematic review on antipsychotic use in catatonia without psychosis found insufficient evidence to support antipsychotic administration in catatonic patients who do not have an underlying psychotic disorder, and raised concerns about worsened outcomes when antipsychotics are given during active catatonic states. This reflects a growing clinical consensus that catatonia should be treated first, before antipsychotics are introduced.

This matters especially because catatonia often appears in people with mood disorders. Someone experiencing catatonia may have an underlying condition like depression rather than a psychotic disorder, which makes antipsychotics even less appropriate as a first response. Even when a person does have a condition like schizophrenia that eventually requires antipsychotic treatment, the general clinical principle is to resolve the catatonia first, typically with benzodiazepines, before reintroducing those medications.

What caregivers can say to ER staff

Emergency physicians are managing fast-moving, high-stakes situations. They are not adversaries, and approaching this as a collaboration, not a confrontation, will serve your family member best. You do not need to recite research. You need a few calm, specific sentences.

Here is language you can adapt:

• “We want to make sure catatonia has been considered before antipsychotics are given. Is it possible to perform a lorazepam challenge first to see if that’s what we’re dealing with?”
• “Our family member has [condition], but we’ve read that antipsychotics can sometimes worsen catatonia. Can the team weigh in on whether that’s a concern here?”
• “We’re not trying to direct treatment — we just want to flag this so the team has the full picture.”

These phrases do three things: they name the concern precisely, they invite clinical judgment rather than override it, and they keep the conversation respectful. ER physicians often welcome informed family input when it is offered without confrontation.

All treatment decisions belong to the treating medical team. This information is meant to help you ask better questions, not to replace professional clinical assessment.

How catatonia is treated and what recovery actually looks like

Catatonia can look permanent from the outside. The stillness, the silence, the absence of the person you know — it can feel like nothing will reach them. Catatonia is, though, one of the most treatment-responsive psychiatric syndromes in medicine, and understanding what treatment actually involves helps set realistic expectations for both patients and families.

Benzodiazepines as first-line treatment

The first treatment doctors reach for is a class of medications called benzodiazepines, most commonly lorazepam. Benzodiazepines work by enhancing the activity of GABA-A receptors in the brain, receptors that regulate inhibitory signaling, which is disrupted in catatonic states. The critical detail here is how these medications are given. Scheduled, high-dose dosing is what works, not as-needed dosing. When lorazepam is given on a fixed schedule, it maintains a consistent level of GABA-A support in the brain, which is what allows the catatonic state to begin lifting. Giving it only when symptoms seem severe is like trying to fill a bathtub with the drain open.

According to research on benzodiazepines as first-line and ECT as second-line treatment for catatonia, this sequenced approach reflects the current clinical standard of care. Many patients show meaningful response within hours to a few days of starting treatment.

ECT for refractory catatonia

When benzodiazepines do not produce an adequate response within a few days, electroconvulsive therapy (ECT) becomes the gold-standard next step. ECT has a response rate of approximately 85 to 90 percent in refractory catatonia, meaning cases that did not respond to medication. Modern ECT is performed under general anesthesia, with carefully controlled electrical stimulation and continuous medical monitoring. It bears almost no resemblance to its portrayal in older films. For people with severe or prolonged catatonia, ECT can be genuinely life-saving, and the same peer-reviewed evidence that supports benzodiazepine sequencing also documents ECT’s established role when first-line treatment falls short.

The recovery timeline: week by week

Recovery from catatonia tends to follow a recognizable arc, though individual timelines vary. In the first hours to days, scheduled benzodiazepines often produce early signs of movement and responsiveness. Over the first one to two weeks, most people reach meaningful stabilization, with motor and verbal function returning more consistently. Full stabilization typically takes one to three weeks, depending on the severity of the episode and the underlying condition driving it.

Residual fatigue is common after the acute phase resolves. Memory gaps for the catatonic episode itself are typical, and many people have little or no recall of the period they were unresponsive. That disorientation, for both the patient and their family, deserves real attention. The emotional processing piece is often underaddressed: families who witnessed the episode may carry their own fear and grief, and patients may feel confused, frightened, or disconnected from an experience they cannot fully remember.

Relapse prevention centers on treating the underlying condition carefully and consistently, watching for early warning signs, and keeping open communication between the patient, family members, and the treatment team. If you or a loved one is processing the emotional aftermath of a catatonic episode, speaking with a licensed therapist at ReachLink is free to start and happens entirely at your own pace.

What your loved one is (and is not) experiencing during catatonia

One of the most frightening questions caregivers face is a deeply human one: is my loved one aware of what’s happening? The honest answer is that it varies, and what we know from both patient accounts and brain research is more reassuring than you might expect.

Many people who recover from catatonic stupor describe having some degree of awareness during the episode. Some recall hearing family members’ voices, feeling a hand on their arm, or experiencing emotions they could not express. Others describe something closer to a dreamlike fog or a blank state with little memory of the episode at all. There is no single universal experience, and your loved one’s inner world during catatonia may be something only they can describe after recovery.

Neuroimaging research adds an important layer to this picture. Brain scans of people in catatonic stupor suggest that cortical activity, including in regions linked to awareness and perception, can remain active even when the body is completely unresponsive. In other words, the brain is not switched off. What appears to be disrupted is the pathway between intention and motor output, the mechanism that translates thought into movement or speech.

On the question of suffering: some patients do report distress after recovery, describing the experience of being aware but unable to respond as frightening. Others describe feeling emotionally muted or detached. Both are valid, and neither should be assumed.

How to be present at the bedside

Given what we know, the most compassionate approach is to behave as though your loved one can hear and feel everything. Speak to them directly, not about them. Use their name. Narrate what is happening with their care in calm, simple terms. Hold their hand if that is appropriate. Avoid side conversations at the bedside that treat them as absent, because they may not be.

After recovery, your loved one may need time and therapeutic support to process what they experienced. Reactions can range from confusion and grief to anger or relief, sometimes all at once. Being prepared for that range, without pushing for a particular response, is one of the most meaningful things you can offer.

Is catatonia dangerous?

Catatonia can be serious, and being honest about that matters. The risks are real, but they are also well understood and, in most cases, preventable. What makes catatonia dangerous is not some quality that puts it beyond the reach of treatment. It is the gap between what catatonia looks like and what clinicians recognize it as.

When catatonia becomes a medical emergency

The most severe form is malignant catatonia, a life-threatening presentation that involves high fever, extreme muscle rigidity, unstable blood pressure and heart rate (a cluster of symptoms called autonomic instability), and a significant decline in consciousness. This is not a psychiatric emergency in name only. People with malignant catatonia typically require ICU-level care, and the condition can deteriorate rapidly without the right intervention.

Historically, untreated malignant catatonia carried mortality rates exceeding 50%. With modern treatment, specifically benzodiazepines and ECT, that number has dropped to under 10%. That shift reflects what becomes possible when the condition is correctly identified and treated promptly.

Complications of prolonged immobility

Even in cases that do not reach the malignant threshold, the physical consequences of staying motionless for hours or days can be severe. Preventing DVT, pressure injuries, and nutritional deficits in people experiencing catatonia is a core part of appropriate medical management, because these complications do not develop inevitably. They develop when catatonia goes unrecognized or unmanaged.

The risks include deep vein thrombosis (DVT, or blood clots forming in the legs), pulmonary embolism (when a clot travels to the lungs), aspiration pneumonia, pressure injuries from sustained immobility, dehydration, and rhabdomyolysis (muscle breakdown that can damage the kidneys). Research on deep vein thrombosis as a serious complication of catatonic immobility also illustrates how ECT can be a life-preserving option when medications alone are not enough.

The real danger is non-recognition

Catatonia becomes most dangerous when it is mistaken for something else. When clinicians see a person who is unresponsive, rigid, and withdrawn and attribute it to treatment-resistant psychosis, the instinct may be to increase antipsychotic medications. That response can worsen catatonia significantly, and in some cases it can trigger the malignant form.

Catatonia is highly treatable, and it is a medical emergency. Both of those things are true at once, and that is exactly why recognition matters so much. The danger lives in the gap between the two.

Processing a frightening experience involving catatonia, whether your own or a loved one’s, takes time. If you are looking for ongoing support, ReachLink connects you with a licensed therapist for free, with no commitment and at whatever pace feels right.

What You Are Feeling After Reading This Makes Complete Sense

Catatonia is one of those conditions that can leave everyone in its wake, patients, families, and caregivers alike, holding a complicated mix of fear, relief, grief, and unanswered questions. Understanding what catatonia actually is and why it is treatable despite how frightening it looks does not make the experience less hard. It does, though, mean you are no longer facing it without a map. The brain can exit this state. People do recover. And the confusion and emotion that linger afterward deserve just as much care as the acute episode itself.

If you are still processing what happened, or trying to figure out what comes next, you do not have to sort through it on your own. Connecting with a licensed therapist at ReachLink is free to try, with no commitment and no pressure to move faster than feels right for you.